Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LKAAEAR1 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | C20orf96 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | RALGAPA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | BCL11A | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | FMC1 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | ZNF10 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | DEAF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |